IGFBP3 Enhances Treatment Outcome and Predicts Favorable Prognosis in ABC-DLBCL

Table 1

Correlations between the expression level of IGFBP3 and clinicopathological factors of ABC-DLBCL patients.

Variables		Expression level of IGFBP3		value
		Negative	Positive
Age				0.472
	>60	34	22
	≤60	57	47
Sex				0.395
	Female	40	35
	Male	51	34
Stage				0.451
	I-II	42	36
	III-IV	49	33
Extranodal infiltration				0.301
	≤1	52	45
	>1	39	24
ECOG score				0.383
	≤1	73	59
	>1	18	10
LDH				0.943
	Normal	48	36
	Elevated	43	33
IPI score				0.383
	≤2	76	61
	>2	15	8
Treatment response				0.037
	CR	24	29
	Non-CR	67	40

ECOG, eastern cooperative oncology group performance status; LDH, lactate dehydrogenase; IPI, international prognostic index; CR, complete response; non-CR, partial response, stable disease, progressive disease; bold, significant difference.